Biogen Inc. (BIIB) Competitors & Peers
The 5 largest companies in the same industry as Biogen Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| LLY | Peer | $1,354.00 | P/E 44.0RSI 61Cap 1.28 T |
| JNJ | Peer | $276.22 | P/E 41.9RSI 59Cap 664.9 B |
| ABBV | Peer | $291.31 | P/E 50.0RSI 60Cap 514.7 B |
| MRK | Peer | $146.73 | P/E 148.2RSI 51Cap 362.4 B |
| AZN | Peer | $186.43 | P/E 26.4RSI 69Cap 289.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- DNLIPartner
Biogen partners with Denali to co-develop LRRK2 inhibitors for Parkinson's disease treatment.
Model-inferred, unverified — treat as a lead, not evidence - TGTXCompetitor
Competes in multiple sclerosis treatment markets, where Biogen operates Ocrevus.
Model-inferred, unverified — treat as a lead, not evidence